SUCAMPO PHARMACEUTICALS INC's ticker is SCMP and the CUSIP is 864909106. A total of 82 filers reported holding SUCAMPO PHARMACEUTICALS INC in Q1 2014. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $186,447,000 | -22.8% | 10,387 | -49.3% | 0.00% | -100.0% |
| Q3 2017 | $241,652,000 | -9.0% | 20,479 | -19.0% | 0.00% | 0.0% |
| Q2 2017 | $265,587,000 | +193.9% | 25,294 | +207.9% | 0.00% | – |
| Q1 2017 | $90,376,000 | +37.6% | 8,216 | +69.5% | 0.00% | – |
| Q4 2016 | $65,690,000 | +200.8% | 4,848 | +173.3% | 0.00% | – |
| Q3 2016 | $21,838,000 | +90.7% | 1,774 | +69.9% | 0.00% | – |
| Q2 2016 | $11,453,000 | +5713.7% | 1,044 | +5700.0% | 0.00% | – |
| Q1 2016 | $197,000 | -99.8% | 18 | -99.7% | 0.00% | – |
| Q4 2015 | $92,260,000 | -12.6% | 5,336 | +0.4% | 0.00% | – |
| Q3 2015 | $105,569,000 | +210.6% | 5,313 | +156.8% | 0.00% | – |
| Q2 2015 | $33,994,000 | +426.5% | 2,069 | +398.6% | 0.00% | – |
| Q1 2015 | $6,457,000 | -18.5% | 415 | -66.0% | 0.00% | – |
| Q3 2014 | $7,924,000 | +1412.2% | 1,219 | +1503.9% | 0.00% | – |
| Q2 2014 | $524,000 | -87.1% | 76 | -87.1% | 0.00% | – |
| Q1 2014 | $4,077,000 | -39.5% | 590 | -17.7% | 0.00% | – |
| Q4 2013 | $6,740,000 | – | 717 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 2,819,708 | $29,607,000 | 8.99% |
| Rubric Capital Management LP | 577,900 | $6,068,000 | 1.25% |
| Malaga Cove Capital, LLC | 84,241 | $882,000 | 0.53% |
| NEA Management Company, LLC | 1,258,507 | $13,214,000 | 0.48% |
| CLARK ESTATES INC/NY | 250,000 | $2,625,000 | 0.45% |
| AlphaMark Advisors, LLC | 98,400 | $1,033,000 | 0.44% |
| Ativo Capital Management LLC | 138,032 | $1,449,000 | 0.40% |
| TFS CAPITAL LLC | 83,694 | $879,000 | 0.34% |
| GLOBEFLEX CAPITAL L P | 103,949 | $1,091,000 | 0.27% |
| Bowling Portfolio Management LLC | 135,021 | $1,418,000 | 0.21% |